ArticleCancer cell international2019

(-)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells.

Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.